| All four miRNAs |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
| miR-199a-3p, miR-122-5p, miR-223-5p |
Glioma |
5 |
0.0014 |
— |
— |
7 |
0.017 |
5 |
0.014 |
| miR-199a-3p, miR-208a-3p, miR-122-5p |
FoxO signaling pathway |
8 |
<6.0 × 10−5
|
4 |
0.016 |
10 |
0.027 |
— |
— |
| miR-199a-3p, miR-208a-3p |
Epstein–Barr virus infection |
7 |
0.003 |
4 |
0.04 |
— |
— |
— |
— |
| miR-199a-3p, miR-223-5p |
Focal adhesion |
14 |
<3.0 × 10−6
|
— |
— |
— |
— |
8 |
0.03 |
| Pathways in cancer |
15 |
<8.0 × 10−7
|
|
|
|
|
12 |
0.009 |
| Melanoma |
7 |
<2.0 × 10−5
|
|
|
|
|
6 |
0.004 |
| Prostate cancer |
5 |
0.004 |
|
|
|
|
6 |
0.010 |
| Endocytosis |
6 |
0.04 |
|
|
|
|
8 |
0.020 |
| miR-199a-3p, miR-122-5p |
Proteoglycans in cancer |
12 |
2.0 × 10−9
|
— |
— |
14 |
0.01 |
— |
— |
| Renal cell carcinoma |
6 |
1.2 × 10−4
|
|
|
8 |
0.004 |
|
|
| Pancreatic cancer |
6 |
1.2 × 10−4
|
|
|
9 |
0.001 |
|
|
| Sphingolipid signaling pathway |
7 |
2.6 × 10−4
|
|
|
10 |
0.01 |
|
|
| Osteoclast differentiation |
7 |
4.2 × 10−4
|
|
|
12 |
0.003 |
|
|
| Central carbon metabolism in cancer |
5 |
<0.002 |
|
|
7 |
0.02 |
|
|
| Toxoplasmosis |
6 |
<0.002 |
|
|
9 |
0.03 |
|
|
| Choline metabolism in cancer |
5 |
0.07 |
|
|
8 |
0.04 |
|
|
| Insulin resistance |
5 |
0.009 |
|
|
10 |
0.007 |
|
|
| Colorectal cancer |
4 |
0.01 |
|
|
8 |
0.004 |
|
|
| Neurotrophin signaling pathway |
5 |
0.01 |
|
|
9 |
0.04 |
|
|
| Epithelial cell signaling in Helicobacter pylori infection |
4 |
0.01 |
|
|
7 |
0.02 |
|
|
| Pertussis |
4 |
0.01 |
|
|
7 |
0.03 |
|
|
| Insulin signaling pathway |
5 |
0.02 |
|
|
11 |
0.01 |
|
|
| Hepatitis B |
5 |
0.02 |
|
|
10 |
0.04 |
|
|
| Tuberculosis |
5 |
0.04 |
|
|
15 |
0.002 |
|
|
